兴业期货日度策略：2025.06.11 重点策略推荐及操作建议： 商品期货方面：苯乙烯支撑走强，PTA 及碳酸锂基本面驱动仍向下。 联系电话：021-80220262 操作上： 品种基本面分析及行情研判： | 品种 | 观点及操作建议 | 方向研判 | 分析师 | 联系人 | | --- | --- | --- | --- | --- | | 股指 | 期指接近上方阻力位，突破仍需利好进一步累积 复中。 | 震荡偏强 | 投资咨询部 从业资格： | | | | 周二 A 股市场小幅调整，科技板块集体回落，沪深两市成交额 | | | | | | 继续回升至 1.45（前值 1.31）万亿元。从行业来看，银行、医药 | | | | | | 板块偏强，国防军工、计算机、综合金融行业领跌。股指期货随现 | | | | | | 货回调，IF、IH 基差略有走弱，IM 持仓量回升，深度贴水稳步修 | | 张舒绮 | 联系人：房紫薇 | | | | | | 021-80220135 | | | 随着五月以来的震荡爬升，当前各指数已接近震荡区间上沿， | | F3037345 | 从业资格： | | | 继续向上突破需政策面 ...

上海开开实业股份有限公司 关于2024年年度权益分派实施后调整 向特定对象发行A股股票发行价格和募集资金总额的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 股票代码：600272 股票简称：开开实业 编号：2025-033 ? 因实施2024年年度权益分派，上海开开实业股份有限公司（ 以下简称："公司"）2024年度向特定对象发行A股股票（以下简 称："本次发行"）的发行价格由8.13元/股调整为8.09元/股；发行 数量不作调整。募集资金总额由不超过人民币159,770,312.85元（含 本数）调整为不超过人民币158,984,235.05元（含本数）。除上述调 整外，公司本次发行的其他事项未发生变化。 一、本次向特定对象发行A股股票的发行价格及募集资金总额 调整依据 关于本次发行相关事项的议案已经公司2024年5月20日召开的第 十届董事会第十八次会议、2025年2月28日召开的第十届董事会第二 十三次会议、2024年6月28日召开的2023年年度股东大会、2025年5月 证券交易所审核通过， ...

Group 1 - The stock price of Yiming Pharmaceutical (002826.SZ) has experienced a continuous six-day limit-up, with a trading volume of 186 million yuan and a turnover rate of 4.94%, indicating increasing market attention [1] - The significant stock price movement is closely related to the equity change of the company's controlling shareholder, with a share transfer agreement signed on May 31, where 44 million shares (22.94% of total shares) will be sold at 15.10 yuan per share, totaling 662 million yuan [1] - The transferor, Gao Fan, has made clear performance commitments in the agreement, ensuring that the net profit attributable to the parent company will not be less than 30 million yuan annually from 2025 to 2027, with annual revenue not less than 600 million yuan [1] Group 2 - Yiming Pharmaceutical has been focusing on the research, production, and sales of chronic disease health products since its establishment in 2003, particularly in diabetes and cardiovascular diseases [1] - The core product, Miglitol tablets, contributed 474 million yuan in revenue in 2024, accounting for 72.72% of the total revenue, showcasing its status as the company's "cash cow" [2] - Miglitol tablets have achieved continuous revenue growth from 2022 to 2024 and have been successfully awarded in various national and provincial procurement programs, demonstrating strong market competitiveness [2]

Core Viewpoint - Shaanxi Tourism Culture Industry Co., Ltd. has finally received acceptance for its IPO plan on the Shanghai Stock Exchange after eight years on the New Third Board, indicating a significant step towards public listing and capital raising in the recovering tourism sector [2]. Company Overview - Shaanxi Tourism is primarily controlled by Shaanxi State-owned Assets Supervision and Administration Commission, with its main business encompassing tourism performances, cable cars, dining, and project investment and management [2]. - The company's core assets include the performance "The Song of Everlasting Regret" and the cable car at Huashan Mountain [2]. Financial Performance - The company is projected to achieve revenues of CNY 1.071 billion (approximately USD 150 million) and CNY 1.245 billion (approximately USD 175 million) for the years 2023 and 2024, respectively [2]. - Net profits attributable to the parent company are expected to be CNY 418 million (approximately USD 59 million) and CNY 503 million (approximately USD 71 million) for the same years, reflecting a positive trend in performance due to the recovery of the tourism industry [2]. Revenue Breakdown - The main revenue contributors are the performance "The Song of Everlasting Regret" and the Huashan cable car, expected to generate CNY 681 million (approximately USD 96 million) and CNY 390 million (approximately USD 55 million) in 2024, accounting for 55.07% and 31.56% of total revenue, respectively [3]. - Both segments exhibit high gross margins of 84.06% and 66.73%, making them significant profit drivers for the company [3]. IPO Fundraising and Investment Projects - The company aims to raise CNY 1.555 billion (approximately USD 220 million) through the IPO, with plans to invest in seven projects, primarily focused on cable car acquisitions and related infrastructure [3][5]. - Key projects include the acquisition of equity in Taihua Cableway, Yaoguang Pavilion, and Shaohua Mountain Cableway, along with the construction of various service centers and tourist facilities [4][5]. - Notably, five out of the seven fundraising projects are related to cable car construction, with a total planned investment of CNY 876 million (approximately USD 124 million) [5]. Strategic Focus - The company is prioritizing cable car operations due to their quicker revenue generation potential compared to traditional performance-based businesses [5]. - The Taihua Cableway project is expected to have a single-direction capacity of 1,500 passengers per hour, with peak capacity reaching 3,000 passengers per hour, indicating strong operational potential [5].

市场表现：今日(20250610) 市场全线下跌，规模指数中上证 50 指数表现较 好，板块指数中上证综指表现较好，风格指数中沪深 300 价值指数表现较好。 银行、医药、交通运输、有色金属、传媒行业表现较好，国防军工、计算机、 综合金融、电子、通信行业表现较差。离境退税、胶原蛋白、熊去氧胆酸、 单克隆抗体、稀土永磁等概念表现较好，移动转售、边缘计算、宽带提速、 寒武纪、机顶盒等概念表现较差。 市场情绪：今日收盘时有 62 只股票涨停，有 2 只股票跌停。昨日涨停股票 今日收盘收益为 2.98%，昨日跌停股票今日收盘收益为-1.59%。今日封板率 62%，较前日下降 4%，连板率 29%，较前日下降 4%。 市场资金流向：截至 20250609 两融余额为 18161 亿元，其中融资余额 18039 亿元，融券余额 123 亿元。两融余额占流通市值比重为 2.3%，两融交易占市 场成交额比重为 9.1%。 折溢价：20250609 当日 ETF 溢价较多的是半导体 ETF 南方，ETF 折价较多的 是沪港深 500ETF 基金。近半年以来大宗交易日均成交金额达到 14 亿元， 20250609 当日大宗交易成 ...

Core Viewpoint - The company, Huan Shi International Logistics Holdings Limited, is launching an IPO in the Hong Kong capital market, highlighting its position as a leading private cross-border logistics provider in China, despite facing significant industry cyclicality and global trade risks [2][12]. Company Overview - Established in 2003, Huan Shi Logistics is a national 5A-level logistics enterprise offering a wide range of services including international sea and air freight, customs clearance, and end-to-end logistics solutions [3]. - The company operates a global logistics network with over 6,000 cross-border routes, covering approximately 200 countries and regions, and ranks first among private cross-border logistics service providers in China [3][4]. Financial Performance - The company has experienced significant revenue fluctuations due to the cyclical nature of the logistics industry. Revenue figures for 2022, 2023, and 2024 were $2.06 billion, $776.29 million, and $1.25 billion, respectively, with corresponding profits of $204.7 million, -$38.43 million, and $51.59 million [7][8]. - In 2023, the company’s revenue decreased by 62.3% year-on-year due to a low point in the cross-border logistics service industry, but it rebounded in 2024 with a significant increase in revenue driven by higher pricing [8][9]. Market Position and Investment - Huan Shi Logistics has attracted investments from major players such as Alibaba's Cainiao and COSCO Shipping, indicating strong market confidence in its business model [6]. - The company’s chairman and CEO, Lin Jie, holds a 31.54% stake, while Cainiao is the second-largest shareholder with a 29.34% stake [6]. Future Outlook - The company is expected to face ongoing challenges from global trade tensions and macroeconomic uncertainties, which may impact its profit performance in the near term [11]. - The ability of Huan Shi Logistics to optimize operations and manage risks will be crucial for its long-term value in a volatile market environment [12].

Core Viewpoint - The article discusses the recent IPO counseling registrations of six companies, highlighting their business models, financial performance, and notable clients, indicating potential investment opportunities in these firms [1][3][21]. Group 1: Company Profiles - Yingpai Rui, a plastic manufacturing company, serves major clients like Sany Heavy Industry and Huawei, and aims for an IPO on the Beijing Stock Exchange after previous attempts [3][5][7]. - Jiangsu Yongcheng, specializing in automotive parts, has seen significant revenue growth, with 2023 revenue reaching 1.23 billion yuan, up 69.9% year-on-year, and is also pursuing an IPO [9][10]. - Xinba Technology, focusing on photovoltaic glass, projects a revenue of 828 million yuan in 2024, marking a 53.99% increase, and is preparing for an IPO [11][12]. - Langxun Technology, a semiconductor testing service provider, has undergone multiple financing rounds and is recognized as a key player in the semiconductor industry, also seeking to go public [14][15]. - Kailong Clean Energy, which provides technical services in the energy sector, is facing declining revenues and profits but is still pursuing an IPO [18][19]. - Energy Technology, a subsidiary of BOE Technology Group, focuses on comprehensive energy services and aims for an IPO, reporting a revenue increase of 34.26% in 2024 [21][22]. Group 2: Financial Performance - Yingpai Rui's revenue for 2022-2024 is projected at 567 million, 569 million, and 617 million yuan, with net profits of 52.66 million, 69.31 million, and 71.15 million yuan respectively [7]. - Jiangsu Yongcheng's revenue growth from 2021 to 2023 shows a consistent upward trend, with net profits increasing significantly [9]. - Xinba Technology's financials indicate a strong growth trajectory, with a projected net profit of 66.29 million yuan in 2024 [12]. - Kailong Clean Energy's revenue is expected to decline to 537 million yuan in 2024, with a net profit drop of 36.04% [19]. - Energy Technology's revenue for 2022-2024 is reported at 642 million, 754 million, and 1.012 billion yuan, with net profits fluctuating during the same period [22].

Group 1 - Lingnan Holdings plans to publicly transfer 3.92% equity of Guangzhou World Wonder at a base price of 23.6576 million yuan, focusing on core business development [1] - Guangkang Biochemical's chlorantraniliprole product has a designed capacity of 10 tons/year but has not yet been produced, with expected minor contribution to overall performance [1] - Palin Bio's controlling shareholder intends to transfer 21.03% of shares to China National Biological, changing the controlling shareholder and actual controller [1][2] Group 2 - Haimer Technology is planning a change of control, leading to a temporary stock suspension for up to two trading days [1] - *ST Zhongdi's stock will be suspended for one day and will resume trading with a change in risk warning status [1] - Jiahua Intelligent's shareholder plans to reduce holdings by up to 1% of total shares due to personal funding needs [5] Group 3 - Bosi Software's director plans to reduce holdings by up to 0.22% of total shares for personal funding needs [6] - Hanjia Design's director intends to reduce holdings by up to 35.6 million shares, representing 0.1577% of total shares [7] - Nanfang Energy plans to invest approximately 51.9788 million yuan in distributed photovoltaic power stations, expecting related transaction amounts to reach 99.3685 million yuan over 25 years [8] Group 4 - Tian Tie Technology's subsidiary temporarily halted production due to steam supply issues, expected to last about one month [9] - Haiguang Information plans a share swap to absorb and merge with Zhongke Shuguang, with stock resuming trading [11] - Tianyima is planning to acquire controlling interest in Xingyun Kaiwu, leading to a stock suspension for up to 10 trading days [12] Group 5 - Xinhua Group's chairman resigned, and Wang Gengyu was elected as the new chairman [13] - Zongyi Co. plans to invest 220 million yuan in Jilai Microelectronics, aiming for a controlling stake post-investment [14] - Zhongying Electronics' controlling shareholder will change to Zhinen Industrial Electronics, with stock resuming trading [16] Group 6 - Huayang Lianzhong plans to jointly invest in a new company with its controlling shareholder, with a registered capital of 402 million yuan [19] - Gaomeng New Materials' chairman and executives plan to reduce holdings by a total of 0.41% of total shares [20] - Beifang Changlong intends to acquire 51% of Henan Zhongsheng for approximately 102 million yuan, expanding its business scope [21]

证券代码：003035 证券简称：南网能源 公告编号：2025-028 南方电网综合能源股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 具体内容详见公司 2025 年 6 月 10 日在指定信息披露媒体《证券时报》《中 国证券报》 南方电网综合能源股份有限公司（以下简称"公司"）二届三十三次董事会 会议于 2025 年 5 月 28 日以电子邮件形式发出会议通知，于 2025 年 6 月 9 日（星 期一）下午 2:30 在广州市天河区华穗路 6 号楼会议室以现场的方式召开。 会议应出席董事 9 名，实际出席董事 9 名。公司监事和部分高级管理人员列 席了会议，董事长宋新明先生召集并主持本次会议。本次会议为临时董事会会议， 会议参与表决人数及召集、召开程序符合《中华人民共和国公司法》和《南方电 网综合能源股份有限公司章程》等有关规定。 二、董事会会议审议情况 （一）审议通过《关于广东省广业环保产业集团有限公司汕头市潮阳区九 座污水处理厂降碳节能项目关联交易的议案》 公司 2025 年第三次独立董事专门会议于 2025 年 ...

Core Viewpoint - Shanxi Kexin Development Co., Ltd. plans to cancel its supervisory board, expand its business scope, and amend its articles of association to enhance corporate governance and operational standards [1][2]. Group 1: Cancellation of Supervisory Board - The company intends to abolish the supervisory board, transferring its powers to the audit committee of the board of directors, in accordance with relevant laws and regulations [1][2]. Group 2: Expansion of Business Scope - The company will expand its business scope to include activities such as investment with its own funds, software development, digital content production services, and management of non-residential real estate [2][4]. - The adjusted business scope will also cover advertising design and agency, cultural and artistic exchange activities, and food sales (limited to pre-packaged food) [2][4]. Group 3: Amendments to Articles of Association - The articles of association will be revised to reflect the cancellation of the supervisory board and the new business scope, ensuring compliance with the Company Law and Securities Law [3][6]. - Key amendments include the definition of the company's legal representative and the responsibilities of shareholders, directors, and senior management [3][6].